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The kinase mammalian target of rapamycin (mTOR) integrates signals triggered by
energy, stress, oxygen levels, and growth factors. It regulates ribosome biogenesis,
mRNA translation, nutrient metabolism, and autophagy. mTOR participates in various
functions of the brain, such as synaptic plasticity, adult neurogenesis, memory, and
learning. mTOR is present during early neural development and participates in axon and
dendrite development, neuron differentiation, and gliogenesis, among other processes.
Furthermore, mTOR has been shown to modulate lifespan in multiple organisms. This
protein is an important energy sensor that is present throughout our lifetime its role
must be precisely described in order to develop therapeutic strategies and prevent
diseases of the central nervous system. The aim of this review is to present our current
understanding of the functions of mTOR in neural development, the adult brain and
aging.
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INTRODUCTION
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that is involved in
the control of cell growth and proliferation. This kinase integrates signals triggered by different
stimuli such as variations in the amino acid supply, changes in the cellular energy state, and
by receptors for various hormones and growth factors and in the brain by transduction of
neurotransmitters and neurotrophin signals (Harris and Lawrence, 2003; Gal-Ben-Ari et al., 2012;
Burket et al., 2015). Several studies have shown that mTOR participates in multiple functions
of the brain. Its activation contributes to processes involved in synaptic plasticity and metabolic
regulation (Garelick and Kennedy, 2011). Additionally, mTOR participates in key processes during
neural development, particularly in axon and dendrite development, neuron differentiation, and
gliogenesis. Furthermore, consistent with its role as a nutrient and growth factor sensor, decreased
mTOR signaling reduces aging and thereby extends lifespan (Cornu et al., 2013). The aim of this
Abbreviations: 4E-BP1, eukaryotic initiation factor 4E-binding protein; DEPTOR, DEP domain-containing mTOR-
interacting protein; eEF2, eukaryotic elongation factor 2; eEF2K, eukaryotic elongation factor 2 kinase; eIF4E, eukaryotic
translation initiation factor 4E; FKBP12, FK506-binding protein; mLST8, mammalian lethal with SEC13 protein 8; mPFC,
medial prefrontal cortex; mSIN1, stress-activated MAP kinase-interacting protein 1; mTOR, mammalian target of rapamycin;
mTORC1, mammalian target of rapamycin complex 1; mTORC2, mammalian target of rapamycin complex 2; NSCs, neural
stem cells; PRAS40, 40 kDa Pro-rich AKT1 substrate 1; PROTOR, Pro-rich protein 5; RAPTOR, regulatory associated
protein of mTOR; Rheb, Ras homolog enriched in brain; RICTOR, rapamycin-insensitive companion of mammalian target of
rapamycin; S6K1, S6 kinase; SVZ, subventricular zone; TSC1, tuberous sclerosis complex proteins, hamartin; TSC2, tuberous
sclerosis complex proteins, tuberin.
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review is to present our current understanding of the functions of
mTOR in neural development, the adult brain and aging.
THE mTOR MULTI-PROTEIN COMPLEX
AND SIGNALING PATHWAYS
Metazoans have a single TOR gene, whereas yeast has two genes,
TOR1 and TOR2. In mammals, the mTOR gene (also known as
FRAP, RAFT1, or SEPT) encodes a protein of 2549 amino acids
with 42 and 45% sequence identity to yeast TOR1 and TOR2,
respectively (Harris and Lawrence, 2003).
mTOR exists in two distinct multi-protein complexes; mTOR
complex 1 (mTORC1) which is sensitive to rapamycin and
consists of the proteins: regulatory associated protein of mTOR
(RAPTOR), 40 kDa pro-rich AKT1 substrate 1 (PRAS40),
mammalian lethal with SEC13 protein 8 (mLST8), and DEP
domain-containing mTOR-interacting protein (DEPTOR). On
the other hand, mTOR complex 2 (mTORC2) is relatively
insensitive to rapamycin and consists of rapamycin-insensitive
companion of mTOR (RICTOR), pro-rich protein 5 (PRR5, also
known as PROTOR), DEPTOR, mLST8, and stress-activated
MAP kinase-interacting protein 1 (mSIN1). However, prolonged
treatment with rapamycin can also inhibit mTORC2, most
likely due to the progressive sequestration of mTOR pools by
rapamycin-FK506-binding protein (FKBP12; Sarbassov et al.,
2005; Weber and Gutmann, 2012).
Rapamycin is an antifungal agent originally isolated from
a strain of the soil bacterium Streptomyces hygroscopicus. It
has potent immunosuppressive and antiproliferative properties
and forms an inhibitory complex with its intracellular receptor,
FKBP12, which binds to the C-terminus of TOR proteins,
thereby inhibiting TOR activity (Weber and Gutmann, 2012).
Because of the promising therapeutic potential of rapamycin,
several rapamycin analogs have been synthesized to improve its
pharmacokinetic properties (Tsang et al., 2007).
Nutrients, energy, stress, oxygen levels, and growth factors
are among the major upstream signaling inputs for mTORC1.
In this regard, the canonical mTORC1 pathway begins with
the activation of tyrosine kinase receptors (Trk) through the
induction of phosphoinositide-3-kinase (PI3K) and protein
kinase B (PKB, also known as Akt) and includes the
phosphorylation and inhibition of tuberous sclerosis complex
proteins, hamartin (TSC1) and tuberin (TSC2). The TSC1/TSC2
complex acts as a GTPase-activating protein (GAP) for Ras
homolog enriched in brain (Rheb). Subsequently, the increase
in GTP-bound Rheb stimulates mTORC1 (Sarbassov et al., 2005;
Weber and Gutmann, 2012).
Mitogens can also activate mTOR independently of Akt
through phospholipase D (PLD) as well as through the
extracellular signal-regulated kinase (ERK)–mitogen-activated
protein kinases (MAPK) pathway (Jaworski and Sheng, 2006).
The cellular energy levels (amino acid concentration) also require
Rheb to activate mTORC1, however, instead of through the
tuberous sclerosis complex (TSC), the signal is transduced via
the Ras-related GTPase (Rag) complex, a heterodimer small
GTPase-containing RagA or B with RagC or D. The increase
in the amino acids concentration, induces the movement of
mTORC1 to the lysosomal membranes where the Rag complex
resides. The complex “Ragulator” consisting of Rag GTPase-
interacting proteins (p18, p14, and MP1) has been identified
in the interaction with the Rag GTPases and its consequent
localization to the lysosome (Sancak and Sabatini, 2009; Kim and
Guan, 2011).
Under conditions of energy deprivation that increase the
AMP/ATP ratio, AMP-activated protein kinase (AMPK) becomes
active and phosphorylates TSC2 to stimulate its GAP activity,
therefore inhibiting Rheb and presumably mTORC1. Oxygen
sensing by the mTORC1 pathway also requires the TSC1/2
complex, but it functions through a distinct mechanism that
involves the hypoxia-inducible factor-dependent expression of
regulated in development and DNA damage responses 1
(REDD1) and REDD2, two growth regulators (Sarbassov et al.,
2005).
It has long been known that translational machinery operates
in neuronal dendrites and synapses, and that local protein
synthesis and its regulation is important for diverse processes
of the central nervous system (CNS), e.g., memory and synaptic
plasticity (Taha et al., 2013). In neurons, neurotransmission
modulates the translation machinery, however, all the
components of this delicate processes have not been identified
yet. mTORC1 is a key downstream molecule in a signaling
cascade beginning with the transduction of neurotransmitters
and neurotrophin signals. Among the receptors found to
activate mTORC1 in neurons, we can mention the muscarinic
acetylcholine receptors, AMPA receptors, the glutamate
metabotropic receptors (mGlu1/5), the dopaminergic D1 and D3
receptors, the opioid receptor, the amino acid/glutamate T1R1–
T1R3 receptors, the serotonin 5-HT6 receptor, the cannabinoid
1 receptor (CB1R), and the GABAB receptors (Gal-Ben-Ari
et al., 2012; Bockaert and Marin, 2015). Burket et al. (2015)
discusses different articles where N-methyl-D-aspartate receptor
(NMDAR) activation is downregulating mTOR signaling activity.
The hallmark of mTORC1 activity is the stimulation of
ribosome biogenesis, mRNA translation, nutrient metabolism,
and autophagy inhibition. In this regard mTORC1 regulates
protein synthesis through the phosphorylation and inactivation
of a repressor of mRNA translation, eukaryotic initiation factor
4E-binding protein (4E-BP1), and through the phosphorylation
and activation of the S6 kinase (S6K1). Thus, S6K1 or 4E-
BP1 phosphorylation is often used as an in vivo readout of
mTOR activity (Hay and Sonenberg, 2004; Sarbassov et al., 2005).
Phosphorylation of 4E-BP1 by mTORC1 signals the onset of cap-
dependent translation; it allows the binding of several important
initiation factors, as well as the positioning of the 40S ribosomal
subunit at the 5′ end of the mRNA to begin the process of
translation (Harris and Lawrence, 2003).
Active S6K1 stimulates the translation of mRNAs containing
unique 5′-terminal oligopyrimidine tracts (TOPs). TOP-
containing mRNAs encode ribosomal proteins, elongation
factors and other critical components of ribosome production.
However, S6K1 activity is not obligatory for this important
process: cells lacking S6K1 still actively translate TOP mRNAs
in response to growth factor stimulation (Weber and Gutmann,
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2012). Furthermore, S6K regulates both the initiation and
elongation phases of translation. It phosphorylates and
inactivates the eukaryotic elongation factor 2 kinase (eEF2K)
resulting in the dephosphorylation of the eukaryotic elongation
factor 2 (eEF2) which mediates the translocation step of
elongation (Wang et al., 2001; Taha et al., 2013). eEF2K is also
named as calcium/calmodulin (CaM)-dependent protein kinase
III (CaMKIII) because it can be activated by elevated levels of
calcium and binding of CaM. In dendrites, this process depends
on glutamate signaling and NMDAR activation, which suggests
a complex regulation of the elongation step, dependent on
particular cellular conditions (Taha et al., 2013; Heise et al.,
2014).
Besides, mTORC2 plays an important role in Akt activation.
Akt itself possesses pleiotropic cellular effects, regulating events
including metabolism, survival, and proliferation. In addition
to Akt, mTORC2 also regulates the actin cytoskeleton through
unknown mechanisms that involve protein kinase C alpha
(PKCα) and Rho. Evidence also points to mTORC2 as a key
player in mRNA translation processes that have been isolated
in polysomes and associated with individual ribosomal proteins
(Sarbassov et al., 2005; Weber and Gutmann, 2012). Inactivation
of mTORC2, but not mTORC1, conditional knockout (CKO)
mice disrupted motor coordination early in life. The Purkinje
cells using of these mice showed developmental alterations in
the processes of climbing fiber elimination and dendritic self-
avoidance (Angliker et al., 2015). Little is known about the
upstream activating signals for mTORC2. Moreover, most of the
activity of this protein complex has been studied in nervous
system cancer cells such as glioblastomas where mTORC2 plays
a central role in the metabolic reprogramming of this cancer
pathology (Masui et al., 2015). The activity of mTORC2 in
transformed cells is not discussed in this review (Figure 1).
mTOR AND EARLY CNS DEVELOPMENT
Early CNS development is a complex, dynamic process that relies
on a precisely orchestrated interplay of inductive signals and
cellular migration. Building this complex and highly organized
system involves the generation of a wide variety of specialized
neural and non-neural cell types that must be placed at
appropriate locations and with the right timing (Budday et al.,
2015; Jiang and Nardelli, 2015).
Neurons, oligodendrocytes, astrocytes, and the ependymal
lining of the central lumen are generated from a common source,
the neuroepithelial cells that are part of the neural tube in early
embryos (Kintner, 2002). Later, cell migration and extensive
synapse formation are responsible for the initial establishment of
the neural circuitry in the brain (Purves, 2012; Bury and Sabo,
2015). The first step in this process is to generate both axons and
dendrites in the newly generated neurons. Axons must grow to
reach the appropriate target cells and begin to make the synaptic
connections that will form neural circuits (Barnes and Polleux,
2009; Purves, 2012).
Clinical evidence from developmental disorders that affect
the CNS, including Lhermitte–Duclos disease (LDD), TSC, and
neurofibromatosis type 1 (NF1) suggest that mTOR plays a
key role in cell differentiation and growth control (Sandsmark
et al., 2007; Crino, 2011). These inherited neurodevelopmental
disorders and cancer syndromes are caused by mutations in genes
that encode negative regulators of the mTOR-signaling pathway.
The continued expression of mTOR in TSC affected individuals
leads to benign overgrowths in multiple organs including brain.
Neurological alterations such as epilepsy, autism, and learning
disabilities are frequent among them and the administration of
mTOR inhibitors result beneficial (Tee et al., 2016). Also, patients
with germinal mutations in phosphatase and tensin homolog
(PTEN; a negative modulator of mTOR) have been observed
in 11 out of 31 LDD patients and associated with granular cell
hypertrophy (Abel et al., 2005). Cognitive impairment is the
most common neurological impairment in NF1 children which
is frequently associated with neuropathological abnormalities
(Gipson and Johnston, 2012).
Neuron Differentiation
During embryonic development, the brain undergoes a dramatic
transformation from a simple tubular structure to a highly
convoluted shape. Neurulation is the process of forming the
neural tube, which will become the brain and spinal cord.
Soon after the neural tube forms, the forerunners of the major
brain regions become apparent as a result of morphogenetic
movements. Eventually, the anterior and posterior regions
of the neural tube become the brain and spinal cord,
respectively. Morphogenesis of the neural tube occurs in a specific
spatiotemporal pattern along the length of the embryo (Sadler,
2005; Purves, 2012; Filas et al., 2013).
Neural stem cells (NSCs) in the early neural plate and
tube and subsequently within each nascent brain region must
follow instructions to differentiate into nerve cells specific to
each region; balanced control of neural progenitor maintenance
and neuron production is crucial for the establishment of
functional neural circuits (Purves, 2012). Mtor null mice die
before the differentiation of cortical neural progenitors into
neurons (Ka et al., 2014). Thus, conditional mutant mTOR
mice were developed to study functions and mechanisms
of mTOR in developing brain. Conditional mutant mTOR
mice had smaller brains with lower numbers of cells in the
proliferating progenitors and cortical layer neurons. According
to these authors an abnormal cell cycle progression disrupted
the population of neural progenitors and thereby the progenitor
self-renewal process (Ka et al., 2014).
Similar disruptive effects were observed in mice with a knock-
in mutation in the PH domain of 3-phosphoinositide dependent
protein kinase-1 (PDK1) and chick embryos treated with
PI3K and TOR inhibitors exhibit deficient neuron production.
Furthermore, rapamycin treatment repressed the expression
of early neuronal differentiation genes, such as neurogenin 2
(Ngn2). Exposure to rapamycin can also disrupt coordination
of cell cycle exit and progression of the neuronal differentiation
program and interfere with the neuroepithelial organization
(Fishwick et al., 2010). Rapamycin treatment in the early days of
development resulted in a decrease in the number of progenitor
stem cells available in the dentate gyrus of the hippocampus,
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FIGURE 1 | mTOR signaling pathway. Nutrients/mitogens, growth factors, energy, oxygen levels, and amino acids are the major upstream signaling inputs for
mTORC1 via different signaling pathways. Through downstream effectors, mTOR controls nutrient metabolism, mRNA translation, and ribosome biogenesis.
as well as an impairment in the development of this region
(Raman et al., 2013). Thus, TOR signaling levels may function
as a checkpoint for the progression of differentiation, and
appears to be essential for the production of NSCs and a proper
development of the dentate gyrus of the hippocampus.
Decreasing mTORC1 activity with Rheb and RAPTOR
knockdowns in neonatal NSCs in the subventricular zone (SVZ)
prevented their differentiation resulting in reduced lineage
expansion and aborted neuron production (Hartman et al., 2013).
Also, the constitutive activation of the translational repressor
4E-BP1 had similar effects: it prevented hyperactive mTORC1
from inducing NSC differentiation and promoted self-renewal.
By contrast, mTORC1-activated S6K1/S6K2 regulated NSC size
but not differentiation, indicating different functions of 4E-BPs
and S6K1/S6K2 in NSCs. These data demonstrated a crucial role
of mTORC1 and 4E-BP for switching cap-dependent translation
on and off in NSCs (Hartman et al., 2013).
On the other hand, Fu et al. (2012) generated CKO mice with
selective deletion of the Tsc1 gene in GABAergic interneuron
progenitor cells, which have impaired growth and decreased
survival. In this case, the cortical and hippocampal GABAergic
interneurons of CKO mice were enlarged and showed increased
mTORC1 signaling. Ectopic clusters of cells with increased
mTORC1 signaling are also observed, suggesting impaired
interneuron migration. Increased mTORC1 signaling may have
negative effects on the CNS development, so regulatory proteins,
such as TSC1, play important roles in keeping mTOR in check
(Fu et al., 2012). In neuronal cultures from rat cortices, a
triiodothyronine (T3)-dependent increase in the size of the
soma in GABAergic neurons was mediated mainly by mTOR
signaling. Both TrkB and mTOR signaling mediate the T3-
dependent reduction of GABAergic axon extension, suggesting
the existence of parallel regulatory pathways for T3-dependent
changes (Westerholz et al., 2013).
When cortical cells from embryonic stages E13.5 and E16.5
were treated with transforming growth factor β (TGFβ) and
insulin growth factor 1 (IGF1), IGF1 induced PI3K, Akt and
mTORC1/mTORC2 primarily in E13.5-derived cells, resulting in
proliferation, survival, and neuronal differentiation. At E16.5,
TGFβ did not directly activate the Akt-mTOR pathway but
required active PI3K-mTORC2-signaling to mediate the neuronal
differentiation of cortical cells (Wahane et al., 2014).
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The data presented in these studies suggest that mTOR plays
an important role in the development of neuronal progenitors,
controlling proliferation and differentiation in various regions
of the CNS. It seems that mTOR may function as a checkpoint
for the differentiation progression, while its hyperactivation does
not inhibit but can affect interneuron migration and neuron
differentiation.
Axon and Dendrite Development
Once nerve cells have been generated, neurons must become
interconnected to form the neural circuits. The first step in
this process is to establish axons and dendrites in the newly
generated neurons. Differentiation of axons and dendrites is a
critical step in neuronal development (Cheng and Poo, 2012;
Purves, 2012). Neurons typically form a single axon and multiple
dendrites, which underlie the directional flow of information
transfer in the CNS. Axons grow to reach appropriate target
cells and begin to make the synaptic connections that will form
neural circuits. Dendrites integrate synaptic inputs, triggering the
generation of action potentials, making presynaptic contacts onto
target cells. There are multiple signaling pathways underlying
the establishment of axon-dendrite development (Barnes and
Polleux, 2009; Purves, 2012). As in neuron differentiation, there
are several studies that show that mTOR plays a pivotal role in
both dendritic and axonal growth.
The pharmacological stimulation of the serotonin receptor
subtype 7 (5-HT7R) using a highly selective agonist, LP-211,
enhances neurite outgrowth in primary neuronal cultures derived
from embryonic mouse brain, via ERK, cyclin-dependent kinase
5 (Cdk5), mTOR, and cell division control protein 42 homolog
(Cdc42). However, the neurite elongation induced by the agonist
stimulation of 5-HT7R is dependent on mTOR, because the
outgrowth is completely inhibited by both rapamycin and torin
1, a specific ATP-competitive mTOR inhibitor (Speranza et al.,
2015).
Methylcobalamin (MeCbl), a vitamin B12 analog, increases
mTOR activity via the activation of Akt and promotes neurite
outgrowth in cerebellar granule neurons while rapamycin
decreased the effect of MeCbl on neurite outgrowth (Okada et al.,
2011).
In a shRNA-induced selective knockdown of RAPTOR and
RICTOR, it was shown that both mTORCs are needed for the
presence of proper dendritic morphology of neurons, whether
grown under basal culture conditions and treated with insulin
or transfected with constitutively active PI3K. Neurons with
knockdown of either RAPTOR or RICTOR produced fewer new
dendrites, whereas the number of retracted dendrites remained
relatively stable (Urbanska et al., 2012).
However, different outcomes have been reported with respect
to the positive role of mTOR in neurite elongation and growth.
The overexpression of the mammalian nicotinamide-adenine
dinucleotide-dependent deacetylase sirtuin 1 (Sirt1) promoted
neurite outgrowth and improved cell viability under both normal
and stress conditions, such as nutrient deprivation or neurotoxic
insult, in primary culture systems. Enhanced Sirt1 expression in
neurons downregulated the protein levels and phosphorylation
of mTOR. Correspondingly, rapamycin markedly improved
neuronal cell survival in response to nutrient deprivation and
significantly enhanced neurite outgrowth in wild-type mouse
neurons. Sirt1 is activated in low energy availability promoting
tissue repair processes, while mTOR is activated during high
energy conditions (Garcia-Rodriguez et al., 2014). In this case,
the above results suggest that mTOR could have negative effects
on CNS development, so regulatory proteins such as Sirt1 play
important roles in keeping mTOR in check (Guo et al., 2011).
Regarding axon and dendrite development, the studies
presented here show that mTOR participates in the processes of
neurite production, promoting outgrowth and elongation, as well
as in maintaining proper dendritic morphology. On the other
hand, Guo et al. (2011) showed that rapamycin also enhances
neurite outgrowth. These apparently contradictory results could
be interpreted in terms of spatiotemporal participation of
mTOR in these processes, which is extremely tightly regulated.
During embryonic development, the temporary silencing of
some proteins has been reported as a switch between stages
(Hirabayashi and Gotoh, 2010; Golbabapour et al., 2013).
However, we must consider that most of these studies used
in vitro models where cell type and culture conditions could
greatly influence the results mainly in key regulators of cell
metabolism such as Sirt1 and mTOR. Further in vivo studies are
necessary to be able to confirm the role of mTOR in axon and
dendrite development.
Gliogenesis
Glia constitute the majority of the brain cells, they perform key
functions vital to CNS physiology, including blood–brain barrier
formation and maintenance, synaptogenesis, neurotransmission,
and metabolic regulation. Glial cell generation starts late in
embryonic stage. Regulation of neuron to glia switch involves
complex neuron–glial interactions as well as spatiotemporal
interplay of both cell-intrinsic factors and extracellular signals
(Jiang and Nardelli, 2015; Molofsky and Deneen, 2015).
mTORC1 signaling pathway has a crucial function in the
process of astrocyte differentiation (Lee da, 2015). Evidence
from different reports show that the axon inhibitor Nogo-66
promotes the NSCs differentiation into the glial lineage via
mTOR and the signal transducer and activator of transcription
3 (STAT3; Rajan et al., 2003; Wang et al., 2008; Cloetta et al.,
2013). Similar to mTORC1, in NF1 genetically engineered
mice and derivative NSC neurosphere cultures, was shown that
hyperactivation of RICTOR containing mTORC2 activation also
increases gliogenesis in the brainstem (Lee da et al., 2010).
Oligodendrocytes are the glial cells that generate CNS myelin;
myelin is a multilamellar differentiation of the oligodendrocyte
plasma membrane that sheaths axons to facilitate electrical
conduction. Progression through the oligodendrocyte lineage
is tightly regulated by a multitude of intrinsic and extrinsic
cues, which control myelination both spatially and temporally
during development and after demyelination. These signals
include growth factors, protein kinases, and extracellular matrix
molecules, all of which influence epigenetic modifications,
transcriptional and translational regulation, and the actin
cytoskeleton in oligodendrocytes (Zuchero and Barres, 2013;
Bercury and Macklin, 2015).
Frontiers in Cellular Neuroscience | www.frontiersin.org 5 June 2016 | Volume 10 | Article 157
fncel-10-00157 June 14, 2016 Time: 19:13 # 6
Garza-Lombó and Gonsebatt Role of mTOR in CNS
Both in vivo and in vitro studies have demonstrated that the
mTOR pathway is an essential mediator during oligodendrocyte
development and that it can be associated to several external
growth factors or hormones with known roles in oligodendroglia
differentiation and myelination (Wood et al., 2013). For example,
conditionally ablation of either RAPTOR or RICTOR in the
oligodendrocyte showed that RAPTOR is a positive regulator
myelination whereas RICTOR ablation has a modest positive
effect on oligodendrocyte differentiation, and very little effect on
myelination (Bercury et al., 2014; Bercury and Macklin, 2015).
Purified oligodendrocyte progenitor cells (OPCs) treated with
CB receptor agonists and antagonists, as well as with PI3K-
Akt and mTOR inhibitors. Maximal phosphorylation of mTOR
was obtained after 10 min stimulation with the agonist HU210,
and this level of phosphorylation was sustained for 60 min. In
contrast, incubation with the other agonists ACEA or JWH133
provoked transient mTOR phosphorylation that peaked at 2 min
and then fell below the basal level (Gómez et al., 2011).
The roles of Rheb1 and mTORC1 in the mouse
oligodendrocyte lineage were examined using separate Cre
drivers to generate Rheb1 or mTor CKO animals for OPCs
as well as for differentiated and mature oligodendrocytes.
Deletion of Rheb1 in OPCs impairs the differentiation to
mature oligodendrocytes, which involves mTORC1. This was
accompanied by a reduction in OPCs exiting the cell cycle,
similarly as during neuron differentiation (Zou et al., 2014).
mTOR is downstream of known activators of PI3K-Akt
signaling and upstream of a number of targets important
for regulating many aspects of oligodendrocyte differentiation
and myelination, including nuclear transcriptional regulators,
mediators of cytoskeletal organization and enzymes necessary for
lipogenesis (Wood et al., 2013). The finding that both Rheb1
and mTORC1 are essential for early stage differentiation of
OPCs to mature oligodendrocytes, which occurs during a narrow
time window, reinforced its importance. Additionally, it seems
that the endocannabinoids may be the extracellular signals that
activate Akt and mTOR during oligodendrocyte differentiation;
the activation of mTOR depended on the agonist used and the
CB receptors activation.
mTOR IN THE ADULT CNS
As we mentioned in the previous section, during early postnatal
life, the neural circuits process diverse types of information and
build the main neural circuits. The sensory systems process
information about the state of the organism and the environment,
and the motor systems organize and generate actions, and
associational systems link the sensory and motor components,
providing the substrate for higher brain functions such as
perception, attention, cognition, emotions, language, rational
thinking, and consciousness (Purves, 2012).
Neurogenesis persists in adult mammals in specific brain areas
known as neurogenic niches. Either physiological or pathological
conditions can modulate the rate of proliferation of adult NSCs
via the differentiation and fate determination of progenitor cells,
as well as the survival, maturation, and integration of newborn
neurons. Adult neurogenic niches can be conceptualized as
remnants of embryonic signaling centers: they are the source of
instructive signals that determine the fate of neighboring stem
cells. Furthermore, these cells may be required for some learning
and memory processes (Zhao et al., 2008; Urban and Guillemot,
2014).
Learning, Memory, and Synaptic
Plasticity
Learning-related changes include modulation of synaptic and
non-synaptic ion channels and receptors, dendritic branching,
spine density, and plasticity through genetic and epigenetic
mechanisms (Sehgal et al., 2013; Stuchlik, 2014). Synaptic
connectivity between neurons is a dynamic entity that is
constantly changing in response to neural activity and other
influences. At the shortest time scales, facilitation, augmentation,
potentiation, and depression provide rapid but transient
modifications in synaptic transmission (Klann and Dever, 2004;
Purves, 2012; Bailey et al., 2015).
The biological processes mediating memory formation
involve numerous tightly regulated molecular and cellular
events. These include mRNA transcription, protein synthesis,
mRNA and protein degradation, mRNA and protein trafficking,
post-translational modifications such as phosphorylation and
ubiquitination, and epigenetic modulation. Such processes can
be brain hemisphere- and brain subregion-specific (Kandel, 2001;
Middei et al., 2014; Rosenberg et al., 2014).
Long-lasting synaptic plasticity and memory rely on protein
synthesis. Not surprisingly, TOR, one of the major controllers
of translation, has been involved in important processes such
as synaptic plasticity, memory and diverse types of behavior in
various organisms, including mammals (Swiech et al., 2008).
As in early CNS development, mTOR also participates in
processes such as synaptic plasticity, adult neurogenesis, learning,
and memory. Its role depends on the regions of the CNS studied
and the stimuli used. Here we describe the participation of mTOR
in signaling pathways in the hippocampus, striatum, amygdala,
medial prefrontal and auditory cortices.
Hippocampus
The hippocampus is essential for memory formation; in addition,
its neuronal connections are highly ordered, and it is easy to
identify specific populations of neurons and synapses. Here,
we reviewed studies that suggest that mTOR participates in
hippocampal neurogenesis, neurite growth and survival, and
dendritic spine formation.
We have mentioned that Akt-mTOR participates in dendritic
development. This signaling pathway was identified as an
unexpected target of the gene disrupted-in-schizophrenia 1
(DISC1) regulating morphogenesis and dendritic development
in new neurons in the adult mouse hippocampus (Kim et al.,
2009). There is also evidence that insulin receptor (IR) regulates
dendritic spine formation and excitatory synapse development
in primary cultures of rat hippocampal neurons through the
activation of the PI3K-Akt-mTOR signaling pathway, which in
turn promotes Rac1-dependent actin cytoskeletal rearrangement
and dendritic spine formation (Lee et al., 2011). Moreover,
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Ezh2 (methyltransferase of histone H3K27, enhancer of zeste
homolog 2) regulates adult neurogenesis and preserves cognitive
functions via the Akt-mTOR pathway (Zhang et al., 2014). The
methyltransferase suppresses PTEN expression, promoting the
activation of Akt-mTOR. The deletion of Ezh2 in progenitor
cells leads to a decrease in neuron production in vivo; more
importantly, Ezh2-null mice showed impairments in spatial
learning and memory, contextual fear memory, and pattern
separation.
Similarly, the administration of ABG001 (tetradecyl 2,3-
dihydroxybenzoate), a neuritogenic substance, enhanced the
survival and neurite growth of newborn cells in adult
hippocampal via TrkA receptor-triggered ERK and PI3K-Akt-
mTOR signaling pathways, that leads to an enhanced preferential
spatial cognitive function. The treatment of amyloid beta25−35
(Aβ25−35)-mice with ABG001 protected the survival and neurite
growth of newborn cells by increasing TrkA receptor-induced
phosphorylation of Akt and mTOR, which was accompanied by
improved spatial cognitive performance (Zhou et al., 2014).
In cultured hippocampal neurons, mTORC1 activity tags
synapses, allowing the RNA-stabilizing protein HuD to capture
the Ca2+ calmodulin-dependent protein kinase II α (CaMKIIα)
in a branch-specific manner, promoting site-specific and long-
lasting forms of plasticity in the tagged branch. Thus, mTORC1
and HuD are good candidates to target the mRNAs coding for
proteins required to strengthen neighboring synapses to facilitate
late-stage plasticity (Sosanya et al., 2015).
Most importantly, Su et al. (2015) showed that the activation
of mTOR pathway components was lower in the hippocampus
of premature rats relative to full-term rats, and this was
associated with poorer learning and memory performance. They
showed that long-term consumption of a protein-rich diet can
restore the impairment in learning and memory in pre-term
rats via upregulation of mTOR-S6K1 signaling. In addition,
mTOR activation and phosphorylation of S6K1 and 4E-BP1
in rat hippocampus was observed during a spatial learning
paradigm. When mTORC1 was inhibited by chronic intra-
cerebral ventricular infusion of rapamycin the phosphorylation
of mTOR substrates were also inhibit as well as the learning-
induced enhancement of protein synthesis and the acquisition
of learning. These results show the activation of mTOR and
its downstream targets during spatial learning in hippocampal
pyramidal neurons (Qi et al., 2010).
There are several recent studies addressing the participation
of mTOR and hormones in memory consolidation and learning.
First, three different studies showed that the sex hormones
estrogen and progesterone induced memory consolidation in
the hippocampus. Estradiol induced the enhancement of object-
recognition memory consolidation via PI3K-mTOR activation
in the dorsal hippocampus (Fortress et al., 2013). Estradiol also
modulated hippocampal synaptic plasticity by activating mTOR
through a signaling pathway that involved TrkB activation, ERK
phosphorylation, and calpain activation (Briz and Baudry, 2014).
In young ovariectomized mice, bilateral dorsal hippocampal
infusion of progesterone significantly increased the levels of ERK
and S6K1. This activation was essential for the progesterone-
induced facilitation of memory consolidation (Orr et al., 2012).
These studies showed that rapid protein synthesis is necessary for
these hormones to modulate the consolidation of hippocampal
LTP and memory.
Also, the neurotrophin brain-derived neurotrophic factor
(BDNF) is an upstream activator of mTOR during and after
training to regulate GluR1 translation in hippocampal synaptic
plasma membranes during IA (inhibitory avoidance) training
memory consolidation (Slipczuk et al., 2009).
The markers for initiation of translation, including eukaryotic
translation initiation factor 4E (eIF4E), 4E-BP1, ribosomal
protein S6, and eIF4F cap-complex formation, undergo diurnal
oscillations in the mouse hippocampus. This diurnal oscillation
in translation initiation has been associated with increased
activity of ERK1/2 MAPK and mTOR, and it was lost in memory-
deficient mice lacking calmodulin-stimulated adenylyl cyclases 1
and 8. Disruption of circadian rhythms leads to loss of diurnal
translation oscillation and causes memory deficits; moreover,
inhibition of protein synthesis during the midday for 4 days
post-training impairs memory persistence (Saraf et al., 2014).
The stimulation of the cannabinoid receptor CB1R by
endogenous and exogenous cannabinoids can trigger the
activation of the mTOR pathway and protein synthesis in the
hippocampus. Contrary to what has been observed in other
cases, this activation causes long-term memory impairment and
amnesic-like effects, probably due to the fact that CB1R is mainly
expressed in GABAergic interneurons. These findings suggest
that the activation of mTOR through CB1R would contribute to
an imbalance between the excitatory and inhibitory inputs in the
hippocampus (Puighermanal et al., 2009).
Moreover, disruption of DISC1 function in adult-born dentate
granule neurons is sufficient to cause several profound behavioral
phenotypes, including pronounced learning and memory deficits,
as well as clear anxiety and depression-like phenotypes. The
knockdown of Disc1 leads to increases in mTOR, indicating that
this signaling abnormality is responsible for the cognitive and
affective deficits. Rapamycin reversed these behavioral deficits
even when associated neuroanatomical abnormalities persisted;
remarkably, the rapamycin treatment, which rescued memory
deficits in shRNA-DISC1 mice, caused memory deficits in control
mice (Zhou et al., 2013).
Most studies also showed that mTOR is involved in both
memory and learning consolidation processes, as well in
the responses of various behavior to hormones, BDNF, and
circadian changes. Furthermore, long-term memory deficits can
be associated with an overactivation of the mTOR signaling
pathway and an imbalance in protein synthesis, suggesting that
mTOR requires mechanisms for tight spatiotemporal control of
its expression.
Striatum
For motor control and learning, the basal ganglia, the motor
cortex, and the cerebellum cooperate to enable movement; the
striatum, part of the basal ganglia, plays a significant role in the
learning processes of motor skilled tasks. Bergeron et al. (2014)
analyzed whether mTOR activity is influenced or engaged during
the execution of motor movement and motor learning. They
showed that mTOR activity of the dorsal striatum is an important
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molecular step involved in learning consolidation during the
acquisition of a complex motor skill in mice, but it is not related
to motor abilities. These data are consistent with the studies in the
hippocampus showing the role of mTOR in memory and learning
consolidation.
Mice with disrupted mTORC2 signaling in the striatum
exhibit altered striatal dopamine-dependent behaviors, such as
increased basal locomotion, stereotypic counts, etc., by altering
the D2R and ERK1/2 pathway (Dadalko et al., 2015).
Amygdala
The amygdala mediates neural processes that relate sensory
experience with emotional significance, and it is also the site
where learning about fearful stimuli occurs. It was found
that rapamycin increases neuronal activity and anxiety-related
behavior, impairs both consolidation and reconsolidation of an
auditory fear memory, and produces impairment of IA memory.
Given the importance of the amygdala in mood regulation,
associative learning, and modulation of cognitive functions, it is
important to consider the role of mTOR in this region; rapamycin
can be used as a treatment for reducing the emotional strength of
established traumatic memories analogous to those observed in
acquired anxiety disorders, but it may also induce alterations in
mood regulation.
In three different studies, Jobim et al. (2012a,b) and
Pedroso et al. (2013) showed that infusion of rapamycin into
the basolateral complex of the amygdala and hippocampus
before and after a reactivation (retrieval) session produced IA
memory impairment. These data showed that non-reinforced
fear memory retrieval could lead to memory reconsolidation
through a mechanism that requires protein synthesis and mTOR
signaling in the amygdala and hippocampus.
The systemic administration of a single low dose of rapamycin
led to enhanced neuronal activity in the amygdala and an
increase in anxiety-related behaviors. The behavioral alterations
correlated to enhanced amygdalar expression of KLK8 and
FKBP51, proteins that have been implicated in the development
of anxiety and depression (Hadamitzky et al., 2014). Moreover,
systemic inhibition by rapamycin administration immediately
or 12 h after either training or reactivation for auditory fear
conditioning, blocks both consolidation and reconsolidation-
like activities that contribute to the formation, retention, and
maintenance of long-term memory. These data suggest that
biphasic translational control through the mTOR pathway
is normally required during the long-term formation and
stabilization of memory through recurrent consolidation and
reconsolidation-like events (Mac Callum et al., 2014).
Medial Prefrontal Cortex
The amygdala is connected with the medial prefrontal cortex
(mPFC), a brain region that is involved in decision making, task
switching, memory consolidation, and the retrieval of remote
long-term memory. It was shown that the PI3K-Akt-mTOR
signaling pathway is involved in the LTP and mPFC-dependent
long-term trace fear memory (Sui et al., 2008). Another study in
the mPFC demonstrated that overexpression of S6K1 produces
antidepressant effects in the forced swim test without altering
locomotor activity. Conversely, expression of dominant-negative
S6K in the mPFC resulted in prodepressive behavior in the forced
swim test and was sufficient to cause anhedonia in the absence of
chronic stress exposure. These data demonstrate a critical role for
S6K1 activity in depressive behaviors and suggest that pathways
downstream of mTORC1 may underlie the pathophysiology and
treatment of major depressive disorder (Dwyer et al., 2015).
These results suggest that fear regulation is mediated by
connections from the mPFC to the amygdala, and it seems that
mTOR participates in this relationship; in the mPFC, the animals
learn to predict aversive events via mTOR, and in the amygdala,
the memory is retained. However, mTOR also participates in
avoiding anxiety and depression.
Auditory Cortex
The auditory cortex of mammals mediates particular aspects
of auditory stimulus processing, task-specific performance, and
learning; one report (Schicknick et al., 2008) showed that the
memory required for the discrimination of complex sensory
stimuli is controlled by dopaminergic activity via mTOR.
In the same way, the dopaminergic inputs to the gerbil
auditory cortex regulate mTOR-mediated, protein-synthesis-
dependent mechanisms, thereby controlling the consolidation of
memory required for the discrimination of complex auditory
stimuli (Schicknick et al., 2008). In a more recent work of
this group, Reichenbach et al. (2015) tested the impact of
local pharmacological activation of different D1/D5 dopamine
receptor signaling modes in the auditory cortex and found
differentially regulation of several protein profiles related to
rearrangement of cytomatrices, energy metabolism, and synaptic
neurotransmission in cortical, hippocampal, and basal brain
structures. These results may be mTOR-mediated, which, in
turn, might enhance the ability to synthesize plasticity-related
proteins locally on demand and facilitate the consolidation of
discrimination memory (Reichenbach et al., 2015).
mTOR AND CNS AGING
During normal aging, the brain suffers both morphological
and functional modifications that affect dendritic trees and
synapses, neurotransmission, circulation, and metabolism; these
changes promote neurodegeneration, impair neurogenesis, and
can be considered a cause of cognitive impairment and sensory
and motor deficits in the elderly (Mariani et al., 2005; Sarlak
et al., 2013). Mounting evidence, however, appears to implicate
increased susceptibility to the long-term effects of oxidative
stress, mitochondrial dysfunction and inflammatory insults as
major contributing factors (Mariani et al., 2005). Understanding
the mechanisms and the detailed metabolic interactions involved
in the processes of normal and pathological neuronal aging and
thus improving health is critical to increasing the quality of life in
the elderly population, especially given the dramatic increase in
the aging population worldwide (Toescu, 2005; Yang et al., 2014).
In recent years, the manipulation of nutrient-sensing and
stress-response pathways has extended the lifespans of organisms
from yeast to mammals. Growth-promoting cell programs may
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accelerate aging by generating metabolic by-products and by
directly inhibiting the clearance of these by-products (Zoncu
et al., 2011). mTOR is a prime target in the genetic control of
aging, and evidence from genetic studies supports the view that
mTOR may be a master determinant of lifespan and aging in yeast
(Kaeberlein et al., 2005), worms (Vellai et al., 2003), flies (Bjedov
et al., 2010), and mice (Harrison et al., 2009).
There is compelling evidence that cellular mechanisms
and signaling pathways regulating brain aging and age-related
neurodegenerative disorders are at least partially controlled by
mTOR. The complex signaling networks underlying the age-
related effects have not been fully elucidated. There are multiple
reviews discussing the relationship between mTOR and CNS
aging (Maiese et al., 2012; Sarlak et al., 2013; Jenwitheesuk et al.,
2014; Perluigi et al., 2015); here, we describe recent studies on this
topic.
One of the mechanisms that relate mTOR to aging is its
participation in inhibiting autophagy. Autophagy is essential for
removing damaged macromolecules and organelles from the
cytoplasm and recycling amino acids (Mizushima et al., 2008).
Studies suggest that autophagy declines with age and that this
leads to an accumulation of damage, such as protein aggregates
and degenerated mitochondria, that contribute to age-related
cellular dysfunction (Cuervo, 2008).
A recent study using naked mole rats which live for up
to 24 years, shows that they maintain high brain autophagy
levels during the majority of their lifespan. Additionally, the
p-mTOR/mTOR ratio showed a significant increase from the
early to intermediate age group and a significant decrease from
the intermediate age group to the old and oldest age groups
(Triplett et al., 2015).
In mouse retinal pigment epithelium (RPE) explants and
cultured human RPE cells, aged RPE cells contained more
lysosome-associated mTOR and showed an increased response
to amino acid stimulation. Increased mTORC1 activity caused a
decreased rate of degradation of internalized photoreceptor outer
segments. These data suggest that the Rag–Ragulator complex
controls the lysosomal distribution of mTORC1 in RPE cells and
may further exacerbate the lysosomal dysfunction of aged RPE
(Yu et al., 2014).
The use of caloric restriction (CR) as a strategy to study
mechanisms behind aging and age-associated diseases is based
on evidence suggesting that CR can delay aging and protect
the CNS from neurodegenerative disorders. Yang et al. (2014)
used C57BL/6J mice with different diets and found that cognitive
function declined with aging, especially after 12 months of age
while CR ameliorated the age-dependent cognition deficit by
deactivating mTOR and its upstream BDNF-Akt signaling in
the hippocampus. Unexpectedly, they found a decline in mTOR
signaling with aging, suggesting that other mediators play a
more important role in regulating age-dependent autophagy than
mTOR by itself in this model.
Dong and colleagues published two other studies using the
CR strategy. C57BL/6 mice were randomly assigned to a NC
group (standard diet), a CR group or a HC group (high-calorie
diet) for 10 months. Activation of the mTOR/S6K1 and p62
signaling pathways was significantly upregulated in hippocampal
neurons of mice in the HC and NC groups and ameliorated by
the CR treatment. They also found that the HC diet and CR
have opposing effects on learning and memory related to age.
Different caloric intake may be an important way to accelerate or
slow the progression of age-related neurodegenerative disorders
(Dong et al., 2015a,b).
Furthermore, when the epigenetic changes in old mice with
dietary restriction (DR) were analyzed, the histone methylation
levels of H3K27me3, H3R2me2, and H3K79me3 in 22-month-old
mouse brain were lower than in 3-month-old animals. However,
either DR or rapamycin treatment prevented the age-induced
losses of H3K27me3, H3R2me2, and H3K79me3. Moreover,
DR and rapamycin each enhanced the levels of H3K18ac and
H3K4me2. The level of H3K4me declined with age and was
further diminished by either DR or rapamycin. The results from
this study suggest that either DR or rapamycin can restore, at least
partially, the age-related alterations in histone methylation levels
(Gong et al., 2015).
Mild mitochondrial uncoupling is similar to the physiological
energetic challenges, including exercise and intermittent fasting,
that seem to protect the CNS from the effects of aging.
The induction of mild mitochondrial uncoupling using 2,4-
dinitrophenol (DNP) triggers a complex integrated cellular
response in the brain that includes suppression of mTOR
and insulin signaling, enhanced autophagy, and upregulation
of cAMP response element-binding (CREB), changes that are
known to play important roles in synaptic plasticity. Moreover,
DNP treatment improves the performance of mice in a learning
and memory task (Liu et al., 2015).
In terms of cognitive function and memory in the elderly,
genome-wide screening showed a novel association of a
polymorphism in the pro-apoptotic gene FASTKD2 (fas-
activated serine/threonine kinase domains 2) with better memory
performance in older adults. Complementary analyses at the
gene and pathway levels identified additional genome-wide
significant associations with episodic memory and the genes
LARS2 (leucyl-tRNA synthetase 2, mitochondrial) and mTor,
which along with FASTKD240, encode proteins with critical roles
in mitochondrial function. These new findings identify potential
targets to help improve risk stratification and therapeutic
development in normal cognitive aging and dementia (Ramanan
et al., 2015).
Adult neurogenesis is another process that decreases with age.
This is mainly because of the reduction in the proliferation of
active NSCs. As mice age, the activity of the mTOR signaling
pathway decreases in the NSCs. Short-term treatment with
ketamine significantly restored the proliferation of NSCs in
the aged mice via mTOR signaling activity. Stimulating mTOR
signaling revitalized the NSCs, restored their proliferation,
and enhanced neurogenesis in the hippocampus of the aged
brain. These data show the potential of mTOR for restoring
neurogenesis in elderly individuals, but it is important to be aware
that overstimulation of mTOR may also lead to other unwanted
effects, such as stem cell depletion, aging, and carcinogenesis
(Romine et al., 2015).
Also Paliouras et al. (2012) showed that mTOR is pivotal
in determining proliferation versus quiescence in the adult
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forebrain niche. mTOR inhibition yielded a quiescence-like
phenotype in vitro, while epidermal growth factor (EGF)-induced
upregulation of mTOR activity enabled the reactivation of the
quiescent SVZ niche within the aging brain. These findings
reveal that the mTOR signaling pathway is a key regulator of
neurogenesis in the adult and aging brain.
Finally, the deficiency of the core clock protein BMAL1
increased mTORC1 activity. A significant increase in
TABLE 1 | mTOR role and signaling components in the different stages of the CNS.
Stage Processes Identified signaling pathway components Reference
Early CNS development
Check point for the progression of differentiation Ngn2, Pax6 Fishwick et al., 2010
NSCs size and switching cap-dependent
translation on and off
S6K1/2, 4E-BPs Hartman et al., 2013
Neural progenitor development GSK3, Sox2 Ka et al., 2014
Soma size increase and axon extension T3, BDNF, TrkB Westerholz et al., 2013
Impaired growth and interneuron migration and
decreased survival
Tsc1 Fu et al., 2012
Proliferation, survival, and neuronal
differentiation
IGF1, TGFβ Wahane et al. (2014)
Neurite outgrowth 5HT7R, Erk, Cdk5, Cdc42
MeCbl
Insulin, RAPTOR, RICTOR
Speranza et al., 2015
Okada et al., 2011
Urbanska et al., 2012
Impaired neurite outgrowth and cell viability Sirt1 Guo et al., 2011
Oligodendrocyte development Cannabinoid receptors
Myelinating proteins: MBP, Tmem10, MOG,
PLP
Gómez et al., 2011
Zou et al., 2014
Adult CNS
• Hippocampus Neurogenesis Ezh2 Zhang et al., 2014
Dendritic spine formation IR, Rac
Disc1
Lee et al., 2011
Kim et al., 2009
Late-stage plasticity HuD, CaMKIIα Sosanya et al., 2015
Enhanced spatial cognitive function TrkA, ERK Zhou et al., 2014
Learning and memory performance S6K1, 4E-BP1 Qi et al., 2010; Su et al., 2015
Memory consolidation Estrogen and progesterone, TrkB, ERK calpain
BDNF, GluR1
Fortress et al., 2013; Briz and
Baudry, 2014; Orr et al., 2012;
Slipczuk et al., 2009
Long-term memory, protein synthesis Circadian oscillations eIF4E, 4E-BP1, S6,
ERK1/2
CB1R
Saraf et al., 2014
Puighermanal et al., 2009
Learning and memory deficits DISC1 Zhou et al., 2013
• Striatum Motor learning consolidation S6K1, 4E-BP Bergeron et al., 2014
• Amygdala Memory consolidation of fear memory KLK8, FKBP51 Jobim et al., 2012a,b; Pedroso
et al., 2013
Hadamitzky et al., 2014
Mac Callum et al., 2014
• Medial prefrontal cortex Trace fear memory Antidepressant effects S6K1 Sui et al., 2008
Dwyer et al., 2015
• Auditory cortex Memory consolidation for the discrimination of
auditory stimuli
Dopaminergic activity Schicknick et al., 2008
CNS aging
Increase lifespan Decreased p-mTOR/mTOR Triplett et al., 2015
Decreased rate of degradation Rag-Ragulator complex Yu et al., 2014
Decreased cognitive function BDNF, Akt Yang et al., 2014
Learning and memory dysfunction p62, S6K1 Dong et al., 2015a,b
Alterations in histone methylation levels H3K27me3, H3R2me2, H3K79me3
H3K4me2
Gong et al., 2015
Enhanced autophagy, synaptic plasticity CREB, decreased mTOR Liu et al., 2015
Better memory performance LARS2, FASTKD40 Ramanan et al., 2015
Adult neurogenesis S6, EGF Romine et al., 2015
Paliouras et al., 2012
Circadian control of aging BMAL1 Khapre et al., 2014
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phosphorylation of downstream targets of mTORC1 was
observed at several time points in different tissues of Bmal1−/−
mice. Treatment with rapamycin increased the lifespan of
Bmal1−/− mice. The authors suggest that the circadian clock
controls the activity of the mTOR pathway through BMAL1-
dependent mechanisms and that this regulation is important for
the control of aging and metabolism (Khapre et al., 2014).
The role of mTOR during aging seems to participate in more
mechanisms than merely autophagy, and it will be challenging to
untangle the role of mTOR in all these processes. The findings
also depend on the model and the approach used. mTOR
increases with age and inhibits autophagy, an important process
in degradation of cellular debris, as well as impairing cognitive
functions, and these effects can be ameliorated with a CR diet
or with mTOR inhibitors such as rapamycin; in fact, rapamycin
has been approved clinically for a variety of uses, including as an
immunosuppressant and as an anticancer drug. Yang et al. (2014)
report evidence of a decline in mTOR with aging, suggesting
that there could be other longevity factors that can also regulate
basal autophagy in the mouse hippocampus during normal brain
aging.
mTOR is also regulated by the circadian rhythm and by
mitochondrial uncoupling and is related to a polymorphism
associated with better memory performance in humans.
mTOR regulates processes such as epigenetic changes (histone
methylation levels), neurogenesis and proliferation in various
niches in the aging brain. Therefore, inhibiting mTOR to increase
the lifespan should be undertaken with caution because this
protein participates in pathways that are essential for health, and
it is likely that alterations in mTOR activity could have negative
effects throughout the entire system (Table 1).
CONCLUDING REMARKS
In early life mTOR participates in neurogenesis, in neurite
outgrowth and elongation and finally in gliogenesis. All of these
processes seem to be regulated by mTOR via translation, and it
likely functions as a cell-cycle checkpoint. There is need of more
in vivo studies that show the timing, region and cell specificity
of mTOR activation/inhibition. It is also important to identified
the signaling pathways and effectors that specifically participate
in each these process.
In the adult brain, mTOR participates in key processes
such as synaptic plasticity, adult neurogenesis, and learning
and memory. Its role depends on many factors, and in
some cases, it seems to have opposite actions. We also
need to understand which mechanisms spatiotemporally
modulate or balance mTOR expression and how their
disruption is associated with neurodegenerative diseases.
Addressing these gaps would help to generate therapeutic
strategies.
Finally, during aging, mTOR seems to increase neurogenesis,
decrease autophagy, and regulate epigenetic changes.
This kinase is an important energy sensor that is present
throughout our lifespan. Several stimuli and transduction
pathways tightly modulate its expression. Its role must be
precisely described in order to develop therapeutic strategies and
prevent CNS diseases.
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